- Home
- RMBL vs TRVI Comparison
RMBL vs TRVI Comparison
Compare RMBL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBL
- TRVI
- Stock Information
- Founded
- RMBL 2013
- TRVI 2011
- Country
- RMBL United States
- TRVI United States
- Employees
- RMBL N/A
- TRVI N/A
- Industry
- RMBL EDP Services
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- RMBL Technology
- TRVI Health Care
- Exchange
- RMBL Nasdaq
- TRVI Nasdaq
- Market Cap
- RMBL 246.9M
- TRVI 211.4M
- IPO Year
- RMBL N/A
- TRVI 2019
- Fundamental
- Price
- RMBL $4.95
- TRVI $4.05
- Analyst Decision
- RMBL Buy
- TRVI Strong Buy
- Analyst Count
- RMBL 3
- TRVI 8
- Target Price
- RMBL $6.67
- TRVI $9.31
- AVG Volume (30 Days)
- RMBL 160.8K
- TRVI 4.2M
- Earning Date
- RMBL 11-12-2024
- TRVI 11-06-2024
- Dividend Yield
- RMBL N/A
- TRVI N/A
- EPS Growth
- RMBL N/A
- TRVI N/A
- EPS
- RMBL N/A
- TRVI N/A
- Revenue
- RMBL $1,250,800,000.00
- TRVI N/A
- Revenue This Year
- RMBL N/A
- TRVI N/A
- Revenue Next Year
- RMBL $6.19
- TRVI N/A
- P/E Ratio
- RMBL N/A
- TRVI N/A
- Revenue Growth
- RMBL N/A
- TRVI N/A
- 52 Week Low
- RMBL $3.13
- TRVI $1.27
- 52 Week High
- RMBL $8.84
- TRVI $4.68
- Technical
- Relative Strength Index (RSI)
- RMBL 38.48
- TRVI 64.87
- Support Level
- RMBL $6.02
- TRVI $4.08
- Resistance Level
- RMBL $5.82
- TRVI $4.68
- Average True Range (ATR)
- RMBL 0.53
- TRVI 0.38
- MACD
- RMBL -0.21
- TRVI 0.15
- Stochastic Oscillator
- RMBL 13.16
- TRVI 73.00
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include power sports, automotive, and vehicle logistics. Powersports and automotive segments consist of the distribution of pre-owned vehicles. The Powersports segment that derives the majority of revenue consists of the distribution principally of motorcycles and other powersports vehicles, while the automotive segment distributes cars and trucks. The vehicle Logistics and transportation service segment offers nationwide automotive transportation services between dealerships and auctions.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.